← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-14 · 마지막 7월 13일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV22행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
AntibodyPhase 2
Cyclophosphamid (Cyclophosphamid)
Essen Biotech·Stomach Cancer
ORR 95%
Overview
Program
Cyclophosphamid
Overview
Company
Essen Biotech
Overview
Modality
ANTIBODY
Overview
Target
Stomach Cancer
Overview
Indication
Stomach Cancer; Stomach Cancer Recurrent
Overview
Phase
PHASE_2
Overview
Status
RECRUITING
MoA
Mechanism
CAR-T therapy induced profound, durable responses in extremely severe patients with seropositive PIRR
MoA
Biomarker
biomarkers
PK/PD
Species
Mouse, =&#x2009, 0.
PK/PD
Animal (cat.)
Mouse
PK/PD
Experiment
PK
Toxicology
Species
Mouse, =&#x2009, 0.
Toxicology
Animal (cat.)
Mouse
Toxicology
Major finding
Polyphenol-rich extract of Ocimum gratissimum leaves prevented toxic effects of cyclophosphamide on the kidney function of Wistar rats.. Cyclophosphamide (CP) is one of the potent and low cost chemotherapy used in clinical setting against a variety of tumors. However, its association with nephrotoxicity limits its therapeutic use. Ocimum gratissimum leaf is a medicinal plant with numerous pharmaco…
Toxicology
CRS
grade 4
Clinical
Primary efficacy
ORR 95%
Clinical
ORR
95.0%
Clinical
Result source
ClinicalTrials.gov NCT03677141
Clinical
Data Tier / Score
A · 62
Clinical
Program phase
PHASE_2
Clinical
Clinical sync
2026년 7월 9일 (5일 전)